Jacobs Levy Equity Management, Inc Pacira Bio Sciences, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$23.9 Billion
Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 652,580 shares of PCRX stock, worth $15.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

652,580

Previous 984,742 33.73%

Holding current value

$15.5 Million

Previous $23.5 Million 28.55%

% of portfolio

0.07%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 17, 2025	SELL	$21.09 - $27.22 $7.01 Million - $9.04 Million	-332,162 Reduced 33.73%	652,580 $16.8 Million
Q2 2025 Aug 14, 2025	BUY	$22.91 - $27.14 $2.96 Million - $3.51 Million	129,254 Added 15.11%	984,742 $23.5 Million
Q1 2025 May 15, 2025	BUY	$18.33 - $27.25 $7.35 Million - $10.9 Million	401,227 Added 88.33%	855,488 $21.3 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $6.95 Million - $9.24 Million	454,261 New	454,261 $8.56 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $3.26 Million - $4.34 Million	-55,041 Closed	0 $0

Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $238,369 - $312,945	-4,723 Reduced 7.9%	55,041 $3.29 Million
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $8.45 Million - $10.2 Million	-162,531 Reduced 73.12%	59,764 $3.59 Million
Q2 2020 Aug 17, 2020	SELL	$30.8 - $52.47 $643,165 - $1.1 Million	-20,882 Reduced 8.59%	222,295 $11.7 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $11,871 - $21,192	418 Added 0.17%	243,177 $8.15 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $1.69 Million - $2.19 Million	46,660 Added 23.79%	242,759 $11 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $427,919 - $539,880	12,000 Added 6.52%	196,099 $7.47 Million
Q2 2019 Aug 13, 2019	BUY	$36.57 - $47.97 $499,546 - $655,270	13,660 Added 8.01%	184,099 $8.01 Million
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $2.59 Million - $3 Million	71,150 Added 71.66%	170,439 $6.49 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $4.1 Million - $5.18 Million	99,289 New	99,289 $4.27 Million
Q4 2017 Feb 13, 2018	SELL	$31.85 - $46.95 $231,868 - $341,796	-7,280 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $259,896 - $287,560	7,280	7,280 $273,000

Others Institutions Holding PCRX

# of Institutions

261

Shares Held

48.9M

Call Options Held

118K

Put Options Held

63.7K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Pacira Bio Sciences, Inc. Transaction History